Form 8-K - Current report:
SEC Accession No. 0001193125-22-259009
Filing Date
2022-10-07
Accepted
2022-10-06 19:01:06
Documents
12
Period of Report
2022-10-06
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K d383407d8k.htm   iXBRL 8-K 25155
  Complete submission text file 0001193125-22-259009.txt   143023

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bmrn-20221006.xsd EX-101.SCH 2848
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmrn-20221006_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmrn-20221006_pre.xml EX-101.PRE 10807
6 EXTRACTED XBRL INSTANCE DOCUMENT d383407d8k_htm.xml XML 3272
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 221299022
SIC: 2834 Pharmaceutical Preparations